Travere Therapeutics, Inc.

CA · United States · Reporting entity ID 100000061305

Total reported 2019–2025

$53.7M

#166 of 2,960 reporting companies — 0.1% of all reported industry payments

$10.8M in general payments across 85,270 records, plus $42.9M in research funding across 11,296 records.

How it breaks down

General payments $10,764,476

Research funding $42,946,645

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.